FR2261776A1 - - Google Patents

Info

Publication number
FR2261776A1
FR2261776A1 FR7504616A FR7504616A FR2261776A1 FR 2261776 A1 FR2261776 A1 FR 2261776A1 FR 7504616 A FR7504616 A FR 7504616A FR 7504616 A FR7504616 A FR 7504616A FR 2261776 A1 FR2261776 A1 FR 2261776A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7504616A
Other languages
French (fr)
Other versions
FR2261776B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierrel SpA
Original Assignee
Pierrel SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel SpA filed Critical Pierrel SpA
Publication of FR2261776A1 publication Critical patent/FR2261776A1/fr
Application granted granted Critical
Publication of FR2261776B1 publication Critical patent/FR2261776B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7504616A 1974-02-27 1975-02-14 Expired FR2261776B1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8928/74A GB1499822A (en) 1974-02-27 1974-02-27 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones
GB2998474 1974-07-05
GB3294574 1974-07-25
GB4998274 1974-11-19

Publications (2)

Publication Number Publication Date
FR2261776A1 true FR2261776A1 (de) 1975-09-19
FR2261776B1 FR2261776B1 (de) 1978-07-21

Family

ID=27447687

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7504616A Expired FR2261776B1 (de) 1974-02-27 1975-02-14

Country Status (18)

Country Link
JP (1) JPS5614677B2 (de)
AR (1) AR218601A1 (de)
BE (1) BE826030A (de)
CA (1) CA1064476A (de)
CH (1) CH608243A5 (de)
DE (3) DE2508136C3 (de)
DK (1) DK144068C (de)
ES (3) ES435067A1 (de)
FI (1) FI56188C (de)
FR (1) FR2261776B1 (de)
GB (1) GB1499822A (de)
IE (1) IE42112B1 (de)
LU (1) LU71908A1 (de)
NO (1) NO144527C (de)
NZ (1) NZ176716A (de)
RO (1) RO78881A (de)
SE (1) SE410736B (de)
YU (3) YU108281A (de)

Also Published As

Publication number Publication date
ES455933A1 (es) 1978-05-01
SE410736B (sv) 1979-10-29
IE42112B1 (en) 1980-06-04
DK144068C (da) 1982-05-03
DE2508136C3 (de) 1979-06-21
CH608243A5 (en) 1978-12-29
YU108281A (en) 1982-02-28
DE2533323B2 (de) 1978-11-16
YU108381A (en) 1982-02-28
NZ176716A (en) 1978-07-10
IE42112L (en) 1975-08-27
DK61575A (de) 1975-10-27
DE2533377B2 (de) 1978-11-16
LU71908A1 (de) 1975-06-24
FR2261776B1 (de) 1978-07-21
RO78881A (ro) 1982-07-06
YU108481A (en) 1982-02-28
DE2533377C3 (de) 1979-08-02
FI750537A (de) 1975-08-28
NO144527B (no) 1981-06-09
NO144527C (no) 1981-09-23
ES435067A1 (es) 1977-07-01
JPS5614677B2 (de) 1981-04-06
ES455934A1 (es) 1978-05-01
CA1064476A (en) 1979-10-16
GB1499822A (en) 1978-02-01
FI56188C (fi) 1979-12-10
SE7502146L (de) 1975-08-28
DE2533323C3 (de) 1979-07-12
DE2533377A1 (de) 1976-02-05
AR218601A1 (es) 1980-06-30
FI56188B (fi) 1979-08-31
DE2508136B2 (de) 1978-11-02
DK144068B (da) 1981-11-30
DE2508136A1 (de) 1975-10-30
DE2533323A1 (de) 1976-02-12
NO750633L (de) 1975-08-28
JPS50126652A (de) 1975-10-04
BE826030A (fr) 1975-06-16

Similar Documents

Publication Publication Date Title
FR2261782A1 (de)
AU7034374A (de)
DK61575A (de)
CH583955A5 (de)
BG22107A1 (de)
BG19728A1 (de)
BG20649A1 (de)
BG20653A1 (de)
BG20840A1 (de)
BG20945A1 (de)
BG21310A1 (de)
BG21514A1 (de)
BG21753A1 (de)
CH585442A5 (de)
BG22305A1 (de)
BG23208A3 (de)
BG26201A3 (de)
BG27068A3 (de)
CH1147874A4 (de)
CH1468974A4 (de)
CH199074A4 (de)
CH51275A4 (de)
CH561530A5 (de)
CH570108A5 (de)
CH570727A5 (de)

Legal Events

Date Code Title Description
ST Notification of lapse